Arquivamento - Art. 36 §1° da LPI
#11.2
03/28/2023
RPI 2725
Application data
Number
112018015480Type
Filing
Publication
PCT
US2017015429 The application was abandoned: the INPI technical office action was not answered in time (art. 36 of the Brazilian IP Act). The technology is in the public domain in Brazil.
Talk to a specialistLatest action published by the INPI: 03/28/2023. We update with every new RPI gazette, published weekly.
Applicants
SORRENTO THERAPEUTICS, INC.
US
Inventors
H. Z. (pessoa física)
US
IPC Classification
Priority claims
US
62/288,912 · 01/29/2016
Abstract
Trata-se de anticorpos de classe IgG anti-PD-L1 que têm capacidade aprimorada para serem fabricados com maiores rendimentos. De modo mais específico, revelam-se anticorpos humanos que se ligam a PD-L1, fragmentos de ligação a PD-L1 que podem ser fabricados com maiores rendimentos.
Publications in the Brazilian Industrial Property Gazette (RPI).
#11.2
03/28/2023
RPI 2725
#6.23
12/20/2022
RPI 2711
#15.35
09/21/2021
RPI 2646
#1.3
05/21/2019
RPI 2524
#1.1
04/09/2019
RPI 2518
From the same holder
Same category
Patent monitoring
Receive alerts on INPI events, decisions, and expiry dates for your portfolio.